发明名称 Compositions and methods for inhibiting expression of mutant EGFR gene
摘要 The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a mutant Epidermal Growth Factor Receptor (EGFR), and methods of using the dsRNA to inhibit expression of mutant EGFR.
申请公布号 US9212364(B2) 申请公布日期 2015.12.15
申请号 US201213659315 申请日期 2012.10.24
申请人 Alnylam Pharmaceuticals, Inc.;Ludwig Institute for Cancer Research Ltd. 发明人 Sah Dinah;Tan Pamela;Cavenee Webster;Furnari Frank;Perez Maria del Mar Inda;Bonavia Rudy
分类号 A61K48/00;C07H21/02;C07H21/04;C12N15/113;A61K31/713 主分类号 A61K48/00
代理机构 Lando & Anastasi, LLP 代理人 Lando & Anastasi, LLP
主权项 1. A method of treating glioblastoma multiforme (GBM), the method comprising administering to a human in need of such treatment a therapeutically effective amount of a first double-stranded ribonucleic acid (dsRNA) and a second dsRNA, wherein the first dsRNA comprises a sense strand and an antisense strand, wherein the antisense strand comprises a region of complementarity which is 19-24 nucleotides in length and which is fully complementary to at least a part of an mRNA encoding a deltaEGFR comprising nucleotides 1-334 and 1136-5616 of the nucleotide sequence of SEQ ID NO: 1, wherein the sense strand and the antisense strand form a duplex structure consisting of 15-30 base pairs; and wherein the second dsRNA comprises a sense strand and an antisense strand, wherein the antisense strand comprises a region of complementarity which is 19-24 nucleotides in length and which is fully complementary to at least a part of an mRNA encoding an IL-6 comprising the nucleotide sequence of SEQ ID NO: 274, wherein the sense strand and the antisense strand form a duplex structure consisting of 15-30 base pairs.
地址 Cambridge MA US